Recital 13, Commission Regulation (EU) No 1086/2011 of 27 October 2011 amending Annex II to Regulati…

In forcesince 27 Oct 2011

Monophasic strains of Salmonella typhimurium have rapidly emerged as one of the most commonly found serotype of salmonella in several species of animals and in clinical isolates from humans. According to the Scientific Opinion on monitoring and assessment of the public health risk of ‘Salmonella typhimurium-like’ strains [EFSA Journal (2010); 8(10): 1826.] monophasic Salmonella typhimurium strains with the antigenic formula 1,4,[5],12:i:- are considered as variants of Salmonella typhimurium and current evidence has shown that these strains appear to pose a public health risk comparable to that of other Salmonella typhimurium strains. Therefore, it is appropriate to clarify that provisions for Salmonella typhimurium are applicable also to these monophasic strains.